PHTHALAZIN-1-ONE DERIVATIVES USEFUL AS GRK2 INHIBITORS | Patent Publication Number 20220242850

US 20220242850 A1

Patent Number-

Application Number17630540

Filled DateJun 29, 2020

Priority DateJul 30, 2019

Publication DateAug 4, 2022

Original Assignee

Current AssigneeJanssen Pharmaceuticals Johnson & Johnson

Inventor/ApplicantsMicheal D. Gaul
Guozhang Xu

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.